Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | LIPC | P11150 | 2/20 | 0.32 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.32 |
| ▸ | NAMPT | P43490 | 1/20 | 0.32 |
| ▸ | LSS | P48449 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16414502 | 0.88 | LIPG (0.42) | LIPGTAAR1LIPCDPP7NAMPT | |
| SCHEMBL22835940 | 0.88 | LIPG (0.42) | LIPGTAAR1LIPCDPP7NAMPT | |
| SCHEMBL22835620 | 0.88 | LIPG (0.42) | LIPGTAAR1LIPCDPP7NAMPT | |
| SCHEMBL18669362 | 0.86 | DPP7 (0.37) | LIPGTAAR1LIPCDPP7NAMPT | |
| SCHEMBL18426119 | 0.81 | KMT2A (0.42) | LIPGTAAR1LIPC | |
| SCHEMBL18426120 | 0.81 | KMT2A (0.42) | LIPGTAAR1LIPC | |
| SCHEMBL2146187 | 0.80 | TAAR1 (0.36) | LIPGTAAR1LIPCDPP7NAMPT | |
| SCHEMBL23364561 | 0.79 | LIPG (0.37) | LIPGTAAR1LIPC | |
| SCHEMBL21767377 | 0.79 | NAMPT (0.37) | LIPGTAAR1LIPCDPP7NAMPT | |
| SCHEMBL21767375 | 0.79 | NAMPT (0.37) | LIPGTAAR1LIPCDPP7NAMPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7732456-B2 | Pyridone derivative | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2010-06-08 | — | — | US | disclosed |
| US-20070208046-A1 | Pyridone derivative | MSD K.K. (JP) | 2007-09-06 | — | — | US | disclosed |
| EP-1741703-A1 | PYRIDONE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2007-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070208046-A1 | Pyridone derivative | CHRM1, XDH, MTR | LIPG 4860/4885TAAR1 92/4885ADORA2A 129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.